🇺🇸 FDA
Patent

US 9616047

Inhibitors of beta-catenin in treatment of colorectal cancer

granted A61KA61K31/404A61K31/4184

Quick answer

US patent 9616047 (Inhibitors of beta-catenin in treatment of colorectal cancer) held by Regents of the University of Minnesota expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/404, A61K31/4184, A61K31/454, A61K31/4545